HARVARD BIOSCIENCE INC — Director's Dealing 2021

Dec 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2021-12-28

Reporting Person: Eade Katherine A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-28	Common Stock	A	1401	$0.00	Acquired	198916	Direct

Footnotes

F1: Represents an award of 1,401 restricted stock units that fully vest on December 31, 2021.

F2: Includes (a) the award described in footnote (1) above, (b) an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022, (c) an award of 3,550 remaining unvested restricted stock units that fully vest on December 29, 2021, and (d) 179,565 shares of common stock held by the Reporting Person.